Skip to main content

Animations

MJFF Publications

5471 - 5480 of 6433 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2021
  • 2023
  • 2022
  • 2022
  • 2023
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
    Journal Name: Cell Reports Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xcrm.2022.100661
    Citation Count: 124
  • Summary Details
    OPEN
    Title: Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-022-01388-7
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Undetected ophthalmological disorders in Parkinson’s disease
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-022-11014-0
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson’s Disease
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-212851
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Simulations predict differing phase responses to excitation vs. inhibition in theta-resonant pyramidal neurons
    Journal Name: Journal of Neurophysiology
    Publisher: American Physiological Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1152/jn.00160.2023
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-022-15874-4
    Citation Count: 99
  • Summary Details
    OPEN
    Title: Synaptic location is a determinant of the detrimental effects of α-synuclein pathology to glutamatergic transmission in the basolateral amygdala
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.78055
    Citation Count: 22
  • Summary Details
    OPEN
    Title: hipFG: high-throughput harmonization and integration pipeline for functional genomics data
    Journal Name: Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/bioinformatics/btad673
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Genome Sequencing in the Parkinson Disease Clinic
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000200002
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Satellite repeat transcripts modulate heterochromatin condensates and safeguard chromosome stability in mouse embryonic stem cells
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-022-31198-3
    Citation Count: 47
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.